IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals & Pharmaceuticals is engaged in the manufacturing and selling of APIs / bulk drugs and speciality chemicals.(Source : 201903 Annual Report Page No: 40)

  • Market Cap: 2,182 Cr.
  • Current Price: 383.55
  • 52 weeks High / Low 409.80 / 146.30
  • Book Value: 113.55
  • Stock P/E: 5.85
  • Dividend Yield: 0.78 %
  • ROCE: 55.53 %
  • ROE: 68.60 %
  • Sales Growth (3Yrs): 42.66 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 10.00
Edit ratios
Pros:
Company has reduced debt.
Company has good consistent profit growth of 135.18% over 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 36.73%
Cons:

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Quarterly Results Figures in Rs. Crores

Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019
193 215 218 263 288 362 423 478 422 493 449 511
167 189 189 231 255 322 348 343 265 348 316 352
Operating Profit 26 26 29 32 32 40 75 136 157 145 133 160
OPM % 14% 12% 13% 12% 11% 11% 18% 28% 37% 29% 30% 31%
Other Income 0 1 1 1 3 4 6 1 2 3 3 4
Interest 17 17 17 16 15 16 14 13 9 8 6 4
Depreciation 7 7 8 8 8 8 8 8 8 9 9 9
Profit before tax 2 3 6 10 13 20 59 115 143 131 121 151
Tax % 14% 6% 24% 8% 10% 27% 35% 29% 29% 35% 28% 35%
Net Profit 2 3 4 9 11 14 38 82 102 85 88 98
EPS in Rs 0.35 0.53 0.79 1.56 2.05 2.56 6.84 14.63 18.08 15.00 15.42 17.22
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
316 301 347 387 471 482 564 385 580 711 983 1,685 1,875
280 268 309 319 402 392 468 373 529 608 863 1,276 1,281
Operating Profit 36 33 39 68 69 89 96 11 51 102 120 410 594
OPM % 12% 11% 11% 18% 15% 18% 17% 3% 9% 14% 12% 24% 32%
Other Income 0 3 1 2 2 3 1 1 1 1 6 10 13
Interest 13 15 15 37 43 57 60 59 61 68 64 51 27
Depreciation 7 10 10 24 24 31 32 29 30 30 30 32 34
Profit before tax 16 11 15 9 4 3 5 -75 -39 6 31 336 546
Tax % 24% -14% 32% 32% -25% 46% 35% 12% -4% 21% 12% 30%
Net Profit 12 13 10 6 5 2 3 -67 -40 5 28 237 373
EPS in Rs 9.24 6.99 4.41 2.40 1.85 0.61 1.15 0.00 0.00 0.83 4.93 41.61 65.72
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% -0% -0% 0% 0% 0%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:18.82%
5 Years:24.50%
3 Years:42.66%
TTM:20.94%
Compounded Profit Growth
10 Years:33.98%
5 Years:135.18%
3 Years:99.36%
TTM:154.32%
Stock Price CAGR
10 Years:24.90%
5 Years:49.92%
3 Years:88.46%
1 Year:77.69%
Return on Equity
10 Years:9.70%
5 Years:14.39%
3 Years:36.73%
Last Year:68.60%

Balance Sheet Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Sep 2019
18 23 28 31 31 31 49 48 56 56 56 57 57
Reserves 48 79 116 140 142 142 160 154 129 132 160 417 589
Borrowings 113 247 269 337 394 400 357 400 453 447 422 284 95
67 75 100 100 124 159 195 100 135 182 214 184 286
Total Liabilities 241 420 508 603 687 727 741 702 772 817 852 942 1,027
127 123 373 351 462 430 411 403 400 374 406 412 418
CWIP 26 187 1 57 12 32 33 4 4 21 7 27 46
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
88 109 135 195 213 265 297 295 369 422 439 503 563
Total Assets 241 420 508 603 687 727 741 702 772 817 852 942 1,027

Cash Flows Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
22 16 31 24 55 53 78 -47 18 83 120 273
-47 -167 -67 -69 -87 -18 -12 -5 -27 -23 -50 -63
25 154 35 59 23 -32 -66 50 9 -60 -70 -197
Net Cash Flow 0 3 -0 13 -9 3 1 -2 -0 1 -1 13

Ratios Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 19% 10% 8% 10% 9% 11% 11% -3% 4% 12% 15% 56%
Debtor Days 37 31 32 29 17 27 32 31 55 58 54 43
Inventory Turnover 6.75 4.81 4.02 2.90 2.59 2.03 2.08 1.38 1.87 1.95 2.96 5.29

Recent announcements

View all announcements

Annual reports

Credit ratings